PJL Life Sciences ApS: Financial statements 2023
CVR: 42773883
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PJL Life Sciences ApS (CVR 42773883) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 44,900 and a net result of DKK 35,022. Equity in the 2023 report amounted to DKK 139,311. The solvency ratio was 21.5%.
- Gross Profit
- DKK 44,900
- Profit/Loss
- DKK 35,022
- Equity
- DKK 139,311
- Total Assets
- DKK 647,898
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PJL Life Sciences ApS has published its interim report for the period October 19, 2021 – December 31, 2022.
About PJL Life Sciences ApS
PJL Life Sciences ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Philip Just Larsen. The company is owned by Philip Just Larsen. In 2025, the company reported a gross profit of DKK 61,012 and a net result of DKK 46,736 compared with DKK 73,783 the year before. Equity in the 2025 report amounted to DKK 259,830.